D-Mark Bio to Distribute Sygnis' Whole-Genome Amplification Technology in Canada | GenomeWeb

NEW YORK (GenomeWeb) – D-Mark Biosciences will distribute Sygnis' TruePrime Single Cell WGA kit in Canada as part of a non-exclusive deal that Sygnis announced today.

D-Mark will promote, market, and sell the kit, which eliminates the need for synthetic random primers in whole-genome amplification. The kit is based on the recently discovered DNA primase TthPrimPol and the Phi29 polymerase and is the first of a number of anticipated products under the TruePrime name, Sygnis said. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.